Drug interactions
Buprenorphine subdermal implant + Scopolamine
Severity: Major
Buprenorphine subdermal implant and Scopolamine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Buprenorphine is an opioid with sedative and respiratory depressant effects, and scopolamine adds central sedation. The combination can increase drowsiness, cognitive impairment and the risk of respiratory depression.
What this interaction means in plain words
Buprenorphine subdermal implant and Scopolamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive CNS depression from opioid partial agonism and central antimuscarinic activity.
What to do
Use only if no alternative is adequate and monitor for excessive sedation and slowed breathing. Counsel the patient about impaired alertness, especially after scopolamine is started.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Scopolamine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Scopolamine
Frequently asked questions
Can I take Buprenorphine subdermal implant with Scopolamine?
MediHelp rates the interaction as major. Buprenorphine subdermal implant and Scopolamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Buprenorphine is an opioid with sedative and respiratory depressant effects, and scopolamine adds central sedation. The combination can increase drowsiness, cognitive impairment and the risk of respiratory depression.
How serious is the interaction between Buprenorphine subdermal implant and Scopolamine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use only if no alternative is adequate and monitor for excessive sedation and slowed breathing. Counsel the patient about impaired alertness, especially after scopolamine is started.
What other medicines interact with Scopolamine?
MediHelp also lists interactions of Scopolamine with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine transdermal. The full list is on the Scopolamine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
